Comparison Between RIRS and Mini-PCNL in the Treatment of Kidney Stones Exceeding 15 mm: Outcome Evaluation and Cost Analysis
<b>Background/Objectives:</b> The optimal surgical approach for kidney stones (KS) measuring 15-20 mm remains debated. RIRS and mini-PCNL are both effective options, but they differ in invasiveness, resource use, and cost. This study aimed to compare perioperative outcomes and hospital costs of RIRS and mini-PCNL using a micro-costing approach. <b>Methods:</b> This retrospective study included patients with KS > 15 mm in diameter who were treated between January 2021 and December 2023 at the Department of Urology, Sapienza University of Rome-Polo Pontino. Clinical parameters, operative time (OT), length of stay (LoS), complications, and stone-free rate (SFR) were compared. Costs were estimated using a micro-costing method, including disposable materials, operating room (OR) time (3.9 EUR/min), imaging, and hospitalization (334 EUR/day). The total cost per treated and per SF patient was calculated for both techniques. <b>Results:</b> A total of 119 patients were analyzed: 62 underwent RIRS, and 57 underwent mini-PCNL. Mean OT was shorter for RIRS (87 vs. 113 min; <i>p</i> < 0.001), and LoS was longer for mini-PCNL (2.24 vs. 1.22 days; <i>p</i> = 0.008). Final SFR was higher for mini-PCNL (94.7% vs. 88.7%; <i>p</i> = 0.043). Complication rates were comparable, with most events classified as Clavien-Dindo I-II. Disposable materials represented the main cost driver (EUR 1097 for RIRS vs. EUR 806 for mini-PCNL). The total cost per treated patient was EUR 3689 for RIRS and EUR 3154 for mini-PCNL (<i>p</i> = 0.009). The cost per SF patient was EUR 4159 for RIRS and EUR 3331 for mini-PCNL (<i>p</i> = 0.007). <b>Conclusions:</b> Both RIRS and mini-PCNL are safe and effective for the management of KS ≥ 15 mm. Mini-PCNL achieves higher SFR and greater cost-efficiency than RIRS. These findings support the use of mini-PCNL as the preferred option in centers with adequate expertise and resources.
Authors
- Giorgio Martino
- Yazan AL Salhi
- Damiano Graziani
- Onofrio Antonio Rera (ORCID: https://orcid.org/0000-0003-4684-632X)
- Andrea Fuschi
- Manfredi Bruno Sequi (ORCID: https://orcid.org/0000-0002-0578-5738)
- Matteo Pacini (ORCID: https://orcid.org/0009-0000-7293-1304)
- Carlo Introini (ORCID: https://orcid.org/0000-0002-7746-9291)
- Pierluigi Russo (ORCID: https://orcid.org/0000-0002-7789-9486)
- Alice Antonioni
- Michele Di Dio (ORCID: https://orcid.org/0000-0002-3227-5573)
- Giorgio Bozzini (ORCID: https://orcid.org/0000-0001-6274-314X)
- Giuseppe Candita
- Paolo Pietro Suraci
- Filippo Gianfrancesco
- Cosimo De NUNZIO
- Paolo Benanti
- Fabio Maria Valenzi
- Antonio Carbone
- Antonio Luigi Pastore
Institutions
- University of Pisa (IT)
- Agostino Gemelli University Polyclinic (IT)
- Ente Ospedaliero Ospedali Galliera (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)
- Ospedale Annunziata di Cosenza (IT)
- Ospedale Sant'Anna (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-12-26
- DOI
- https://doi.org/10.3390/jcm15010177
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00